Cyclodextrin inclusion compound of prasugrel and acid addition salt thereof and preparation method thereof
A technology of cyclodextrin inclusion compound and acid addition salt, which is applied in the direction of non-active ingredients of polymer compounds, drug combinations, blood diseases, etc., can solve the problems of stability and bioavailability without much improvement, and achieve Improve bioavailability, improve stability, and easy synthesis
Inactive Publication Date: 2010-08-25
SHANDONG XINHUA PHARMA CO LTD
View PDF3 Cites 11 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
However, there are some shortcomings in using prasugrel directly as a pharmaceutical preparation. For example, patent WO2008073759 points out that prasugrel is easy to be hydrolyzed and oxidized during storage. salt, but its stability and bioavailability have not changed much, and cyclodextrin drug inclusion complexes have been widely used in pharmacy, such as increasing the solubility of drugs, improving the stability of drugs, and improving the efficacy of drugs. Bioavailability, etc. Therefore, the cyclodextrin inclusion complex of prasugrel and its acid addition salts may be able to overcome the shortcomings of prasugrel and its acid addition salts, and improve their stability and bioavailability
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
Embodiment 2
Embodiment 3
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention provides a cyclodextrin inclusion compound of prasugrel and acid addition salt thereof, which has stable inclusion structure, can be easily synthesized and saved and are stable in the air, and the water solubility of the prasugrel and the acid addition salt thereof is increased. The prasugrel and the acid addition salt thereof react with various cyclodextrins in water and organic solvents to prepare the stable inclusion compound which can be used as a therapeutic drug or has potential application.
Description
technical field The invention relates to a chemical synthesis preparation process, in particular to a platelet inhibitor prasugrel and a cyclodextrin inclusion complex of an acid addition salt thereof and a preparation method thereof. Background technique Thienopyridines such as ticlopidine and clopidogrel have been used to treat thrombosis and related diseases. Prasugrel ({2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine}) as A new generation of thienopyridine oral antiplatelet drugs is also on the market with the trade name Effient. Prasugrel structural formula such as I, is a kind of adenosine diphosphate (ADP) receptor antagonist, it belongs to prodrug, itself does not have activity and effectively converts into its active metabolite R-138727 in vivo; R- 138727 reduces the dependence on cytochrome P-450 enzymes, and rapidly, specifically, and irreversibly binds to the purine base receptors of platelet P2Y12, inhibiting ADP-regu...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): A61K31/4365A61K47/40A61P7/02
Inventor 李进都韩勇孙科常森
Owner SHANDONG XINHUA PHARMA CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com